Categories: Research

UCSF technology used to trigger cell death becomes basis of company’s cancer therapy research and development7

A technology developed in the laboratory of James Wells, PhD, chair of the Department of Pharmaceutical Chemistry, UCSF School of Pharmacy, will drive a new approach to cancer treatment that switches on or triggers, with small molecules, the enzymes called caspases that promote cell death.

School of Pharmacy women highlighted for their influence in science and education8

Four members of the UCSF School of Pharmacy faculty have been named from among a list of 14 as key women in science research and education at UCSF. They are (pictured left-to-right):

Burchard comments on asthma genetics9

Asthma specialist and genetics researcher, Esteban G. Burchard, MD, MPH, joint faculty member in the UCSF Schools of Pharmacy and Medicine, discusses the differences in the incidence of asthma and response to asthma drugs among various subgroups within the larger Latino population.

Benet honored for lifetime accomplishments in drug clearance research and discovery10

For his historic contributions to what is now known about the rate at which drugs are broken down and "cleared" from the body, Leslie Benet, PhD, was honored by the American Society for Clinical Pharmacology and Therapeutics (ASCPT) with the Oscar B. Hunter Memorial Award in Therapeutics.

Fujimori unveils enzymatic process in bacteria that leads to antibiotic resistance11

Research results published from the UCSF research laboratory of Danica Galonić Fujimori, PhD, have revealed a radical approach employed by bacteria to alter their ribosomes and thereby evade antibiotics. These findings could ultimately lead to the development of ways to block this enzymatic...

Wells wins ASBMB-Merck Award12

James Wells, PhD, chair of the UCSF School of Pharmacy's Department of Pharmaceutical Chemistry, has been named the 2010 recipient of the American Society for Biochemistry and Molecular Biology (ASBMB) Merck Award for his pioneering studies in the field of protein engineering.

Dill receives UCSF Academic Senate faculty research lectureship13

Ken Dill, PhD, an internationally recognized expert on protein folding and UCSF School of Pharmacy associate dean of research, has been named recipient of the 53rd UCSF Academic Senate Research Lectureship for his distinguished contributions to science.

Small Molecule Discovery Center and Genentech partner in drug discovery14

UCSF's Small Molecule Discovery Center (SMDC) announced on February 18, 2010 that it has signed its first major industry partnership agreement since the SMDC was founded in 2005. The agreement is with Genentech, Inc. to discover and develop drug candidates for neurodegenerative diseases.

Symposium on the future of therapeutics inaugurates new UCSF department15

In the first symposium held by the newly minted UCSF Department of Bioengineering and Therapeutic Sciences, researchers described progress in the fields of systems biology, pharmacogenomics, and bioengineering, and how scientists in these fields are working in concert to develop novel diagnostics...

Burchard joins discussion on race and ethnicity16

Burchard participates in a panel and explains the differences between race and ethnicity and more with NPR’s Science Friday aired January 15, 2010.

Pages